ACTIVE

EXTRAPHAR

Export PDF
Financial year 2024 · closed on 31/12/2024
Net result
-35,6 k €
-334.3% YoY
Gross margin
-35,3 k €
-295.1% YoY
Equity
-29,1 k €
-542.5% YoY

What does EXTRAPHAR do?

EXTRAPHAR is a Private limited company incorporated in 2022. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Woluwe-Saint-Lambert.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0788.510.921
Incorporation
12/07/2022
Legal form
Private limited company
Registered office
Avenue de Calabre 38 - b9
1200 Woluwe-Saint-Lambert · BruxellesSee on map
Contributed capital
2 500,00 €
Latest accounts
31/12/2024
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods21201Manufacture of pharmaceutical preparations21201Manufacture of pharmaceutical preparations46900Non-specialised wholesale trade46900Non-specialised wholesale trade+6
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202420232022
Income statement
Gross margin-35,3 k €18,1 k €-10,0 k €
EBITDA-35,5 k €17,7 k €-10,4 k €
Operating result-35,5 k €15,3 k €-11,1 k €
Net result-35,6 k €15,2 k €-11,1 k €
Balance sheet
Equity-29,1 k €6,6 k €-8,6 k €
Total assets14,9 k €57,1 k €35,3 k €
Cash3,5 k €3,2 k €147,7 €
Debts43,9 k €50,5 k €43,9 k €
Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active

Active mandates

Marie Hicintuka Marie

Director · since 12 juillet 2024

Active
Annual accounts

Full financial information

202420232022
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/07/2022
Closing of the financial year31/12/202431/12/202331/12/2022
Length of the financial year12 months12 months6 months
Filing date05/09/202506/08/202430/07/2023
General meeting30/06/202501/06/202401/06/2023
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

3 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202430/06/202505/09/2025FrenchPDF
Micro model31/12/202301/06/202406/08/2024FrenchPDF
Micro model31/12/202201/06/202330/07/2023FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active

Active mandates

Marie Hicintuka Marie

Director · since 12 juillet 2024

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-35,6 k €↓
  2. 2023
    Annual accounts 202315,2 k €↑
  3. 2022
    Annual accounts 2022-11,1 k €
  4. 12/07/2022
    IncorporationPrivate limited company